As ALS progresses, annual healthcare costs for U.S. patients increase from an average of $31,000 to over $120,000, a Biogen ...

The Centers for Medicare and Medicaid Services is directing all Medicare Advantage plans to cover Qalsody for treating ...

HEALEY ALS, a platform trial testing multiple potential treatments for amyotrophic lateral sclerosis, is amending its master ...

Columnist Kristin Neva must take on more caregiver duties as her husband's ALS progresses, which means she must shift her ...

Neurosense is finalizing the protocol of a Phase 3 study of PrimeC for ALS, and plans to submit the protocol for FDA approval ...

The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is amending its master protocol to allow a longer follow-up time ...